Kubitza, D., Roth, A., Becka, M., Alatrach, A., Halabi, A., Hinrichsen, H., & Mueck, W. (2013). Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor. Blackwell Science Inc.
Čikaški stil citiranjaKubitza, Dagmar, Angelika Roth, Michael Becka, Abir Alatrach, Atef Halabi, Holger Hinrichsen, i Wolfgang Mueck. Effect of Hepatic Impairment On the Pharmacokinetics and Pharmacodynamics of a Single Dose of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor. Blackwell Science Inc, 2013.
MLA način citiranjaKubitza, Dagmar, et al. Effect of Hepatic Impairment On the Pharmacokinetics and Pharmacodynamics of a Single Dose of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor. Blackwell Science Inc, 2013.